Does loss of ARID1A expression affect neoadjuvant chemoradiotherapy response in rectal carcinomas?
{{output}}
This study evaluated the difference of ARID1A protein immunoexpression between responders and non-responders to neoadjuvant chemoradiotherapy in locally advanced rectal cancers. The biopsies before neoadjuvant chemoradiotherapy and resection materials after me... ...
